| Soe Min Tun, MD | |
|
815 N Kansas Ave Ste 100, Hastings, NE 68901-4470 | |
| (402) 460-5899 | |
| (402) 460-5898 |
| Full Name | Soe Min Tun |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 15 Years |
| Location | 815 N Kansas Ave Ste 100, Hastings, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801279799 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 33036 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Lanning Healthcare | Hastings, NE | Hospital |
| York General Hospital | York, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Mary Lanning Memorial Hospital Association | 4587575550 | 117 |
News Archive
Johns Hopkins Kimmel Cancer Center scientists have found that interferon, used for 30 years to treat blood cancers, multiple sclerosis and hepatitis, selectively kills colon cancer cells when combined with another standard chemotherapy agent.
Some HIV-positive people in Uganda "cannot be put on the national antiretroviral [ARV] programme because it is already saturated and funds for new patients are not available," the Independent reports. According to the newspaper, roughly 360,000 HIV-positive Ugandans are eligible for antiretroviral treatment because their CD4 counts are below the WHO's threshold of 350; however, about half of them currently do not have access to ARVs.
As the Obama administration published rules for "navigators," who will be hired in every state to help consumers shop in new insurance marketplaces, news outlets examine how states are setting up those marketplaces and the impact on consumers.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today the European approval of its new lithotripter, the Sonolith i-move. The EDAP sales team and distributors will begin marketing Sonolith i-move immediately and will officially introduce the product to distributors, partners and visiting urologists at the European Association Urology (EAU) congress, Booth #14, from April 17-19, 2010 in Barcelona, Spain.
A new report has reignited fears over another possible outbreak of the deadly Creutzfeldt-Jakob Disease (CJD) in Britain.
› Verified 2 days ago
| Entity Name | The Mary Lanning Memorial Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588812796 PECOS PAC ID: 4587575550 Enrollment ID: O20080922000295 |
News Archive
Johns Hopkins Kimmel Cancer Center scientists have found that interferon, used for 30 years to treat blood cancers, multiple sclerosis and hepatitis, selectively kills colon cancer cells when combined with another standard chemotherapy agent.
Some HIV-positive people in Uganda "cannot be put on the national antiretroviral [ARV] programme because it is already saturated and funds for new patients are not available," the Independent reports. According to the newspaper, roughly 360,000 HIV-positive Ugandans are eligible for antiretroviral treatment because their CD4 counts are below the WHO's threshold of 350; however, about half of them currently do not have access to ARVs.
As the Obama administration published rules for "navigators," who will be hired in every state to help consumers shop in new insurance marketplaces, news outlets examine how states are setting up those marketplaces and the impact on consumers.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today the European approval of its new lithotripter, the Sonolith i-move. The EDAP sales team and distributors will begin marketing Sonolith i-move immediately and will officially introduce the product to distributors, partners and visiting urologists at the European Association Urology (EAU) congress, Booth #14, from April 17-19, 2010 in Barcelona, Spain.
A new report has reignited fears over another possible outbreak of the deadly Creutzfeldt-Jakob Disease (CJD) in Britain.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Soe Min Tun, MD 815 N Kansas Ave Ste 100, Hastings, NE 68901-4470 Ph: (402) 460-5899 | Soe Min Tun, MD 815 N Kansas Ave Ste 100, Hastings, NE 68901-4470 Ph: (402) 460-5899 |
News Archive
Johns Hopkins Kimmel Cancer Center scientists have found that interferon, used for 30 years to treat blood cancers, multiple sclerosis and hepatitis, selectively kills colon cancer cells when combined with another standard chemotherapy agent.
Some HIV-positive people in Uganda "cannot be put on the national antiretroviral [ARV] programme because it is already saturated and funds for new patients are not available," the Independent reports. According to the newspaper, roughly 360,000 HIV-positive Ugandans are eligible for antiretroviral treatment because their CD4 counts are below the WHO's threshold of 350; however, about half of them currently do not have access to ARVs.
As the Obama administration published rules for "navigators," who will be hired in every state to help consumers shop in new insurance marketplaces, news outlets examine how states are setting up those marketplaces and the impact on consumers.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today the European approval of its new lithotripter, the Sonolith i-move. The EDAP sales team and distributors will begin marketing Sonolith i-move immediately and will officially introduce the product to distributors, partners and visiting urologists at the European Association Urology (EAU) congress, Booth #14, from April 17-19, 2010 in Barcelona, Spain.
A new report has reignited fears over another possible outbreak of the deadly Creutzfeldt-Jakob Disease (CJD) in Britain.
› Verified 2 days ago
Richard French, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2115 N Kansas Ave, Ste 105a, Hastings, NE 68901 Phone: 402-463-2454 Fax: 402-463-2450 | |
Donald R. Snodgrass, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 223 E 14th St, Ste 100, Hastings, NE 68901 Phone: 402-463-2929 | |
James Hervert Jr., MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2115 N Kansas Ave, Hastings, NE 68901 Phone: 402-463-2454 Fax: 402-463-2450 | |
Dr. Shanon Dail Smith, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 715 N Saint Joseph Ave, Hastings Radiology Associates, Hastings, NE 68901 Phone: 402-461-5191 | |
Dr. Ramez J Habash, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 715 N Kansas Ave, # 202, Hastings, NE 68901 Phone: 402-463-2344 Fax: 402-463-2355 | |
Abhijeet Basoor, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 715 North Kansas, Ste 100, Hastings, NE 68901 Phone: 402-460-5555 Fax: 402-460-5593 | |
Daniel B Einspahr, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 715 N Saint Joseph Ave, Hastings, NE 68901 Phone: 402-463-4521 Fax: 402-347-4952 |